Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of Engineered Donor Grafts (TregGraft / Orca-T) in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Multiple Cancer Types

This study will evaluate the safety, tolerability, and efficacy of an engineered donor graft ("TregGraft" / "Orca-T", a T-cell-Depleted Graft With Additional Infusion of Conventional T Cells and Regulatory T Cells) in participants undergoing myeloablative allogeneic hematopoietic cell transplant transplantation for hematologic malignancies.
Leukemia, Myelodysplastic Syndrome, Phase I
I
Dholaria, Bhagirathbhai
NCT04013685
VICCCTTP2086

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: